medicines.org.uk NCBI StatPearls Semaglutide Gastrointestinal adverse effects review
Ozempic Updates from 2024 December 19, 2024: Two New Studies Link Ozempic to NAION, Possibly Leading to Investigation by European Medicines Agency The findings of two medical studies conducted by the University of Southern Denmark have led the Danish Medicines Agency (DMA) to ask for an investigation into the link between Ozempic use and the rare eye condition NAION
Semaglutide: Common side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, bloating, belching, gas, stomach flu, and heartburn
Intervention can address underlying issues, ensure appropriate management of side effects, and optimize the safety and effectiveness of treatment